TrialPloS one2020

Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients' knowledge to manage adverse effects.

Juliette Périchou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.